Evaluation of Fluorodeoxyglucose Positron Emission Tomography in the Detection of Axillary Lymph Node Metastases in Patients With Early-Stage Breast Cancer
- 1 January 2003
- journal article
- clinical trial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 10 (6) , 622-627
- https://doi.org/10.1245/aso.2003.12.019
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Is Lymphatic Mapping in Breast Cancer Adequate and Safe?World Journal of Surgery, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Positron emission tomography in breast cancer: a clinicopathological correlation of results.The British Journal of Radiology, 1999
- Staging of the Axilla in Breast CancerAnnals of Surgery, 1998
- Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.Radiology, 1997
- Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistryEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucoseJNCI Journal of the National Cancer Institute, 1996
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurgical Oncology, 1993
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 1989